Fundraising Fox
🦊/Companies
Sign in

iFAST

Whiteley, GB · Founded 2022 · 27 employees on LinkedIn · 8 known investors

Find your way into iFAST

iFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process. The company serves clinical laboratories and hospitals to help combat antimicrobial resistance.

BiotechHealthtechMedical Devices

Founders & leadership

TK
Toby KinginCEOToby King is CEO of iFAST Diagnostics, which develops rapid antimicrobial susceptibility testing technology for clinical laboratories and hospitals. He has experience leading technology development teams in regulated medical device environments.

Investors · 8

Meridian Health Ventures✓ verifiedLondon
Cambridge Capital Group✓ verifiedCambridge
Innovate UK✓ verifiedLondon
Raw Ventures✓ verifiedLondon
Future Planet CapitalLondon
UK Innovation & Science Seed FundLondon · $127K – $635K

Also in the syndicate · 2

OKG CapitalsQantX

Funding

SEC filings, press & company announcements
  • Undisclosed amountshare placementJan 2022
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 1

by search overlap
BioMérieux5 shared keywordsbioMérieux develops in vitro diagnostic solutions for clinical laboratories and healthcare professionals, covering areas such as antimicrobial stewardship, sepsis, and infectious disease detection. It also provides diagnostics for food safety and quality and pharmaceutical quality control.

Companies competing with iFAST for the same Google search keywords, organic and paid, via search-intersection analysis.

Companies House · registry record

View on Companies House ↗
Registered name
IFAST UK HOLDINGS LIMITED
Company number
13045848
Status
Active
Company type
Private limited company
Incorporated
26 Nov 2020
Registered office
66 Lincoln's Inn Fields, London, WC2A 3LH
Nature of business (SIC)
64205 — Activities of financial services holding companies
Previous names
EAGLES PEAK HOLDINGS LIMITED (2020–2024)
Accounts
last made up to 31 Dec 2024 · next due 30 Sept 2026
Confirmation statement
last made up to 12 Sept 2025 · next due 26 Sept 2026

Current officers · 3

  • Chung Chun Lim — director, appointed 3 Oct 2022
  • Vincent Tong — director, appointed 6 Jan 2022
  • Wong Weiyi — director, appointed 11 Apr 2023

Source: Companies House public register · retrieved 9 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

How Singapore Fintech iFAST Became A Regional Wealth Engineforbes.com · Jul 2026iFAST Diagnostics Raises £5M To Advance Rapid Infection Testing Technologystartuprise.co.uk · May 2026UK Dx Firm iFAST Raises £5M to Expand Commercialization of AST Platform | 360Dx360dx.com · May 2026iFAST’s Expansion Plans: Too Ambitious or Just Getting Started?sg.finance.yahoo.com · Feb 2026iFAST Diagnostics funding news - London-based iFAST Diagnostics Raises Over €5.9 Million in Seed Fundingstartuprise.co.uk · Nov 2024iFAST raises $105m from latest share placement | Singapore Business Reviewsbr.com.sg · Jan 2022

Frequently asked questions

What does iFAST do?
iFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process. The company serves clinical laboratories and hospitals to help combat antimicrobial resistance.
Who are iFAST's investors?
iFAST's investors include Meridian Health Ventures, Cambridge Capital Group, Innovate UK, Raw Ventures, Future Planet Capital, UK Innovation & Science Seed Fund.
Where is iFAST headquartered?
iFAST is headquartered in Whiteley, GB.